Komori
General Meetings of Shareholders4599StemRIM Inc.Pharmaceuticals

Notice of Convocation of the 21st Annual General Meeting of Shareholders

The 21st Annual General Meeting of Shareholders will be held on 28 October 2026, with the election of directors, Audit and Supervisory Board members and substitute Audit and Supervisory Board members, and the gratis issuance of share acquisition rights as stock options, placed on the agenda.

Worth reading
50Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Neutral
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Definitive
How definitive the wording is.

Resolutions for the General Meeting of Shareholders

Annual (21st fiscal year)
2026
Oct 28
Date and time(Wednesday), 2:00 p.m.22 days from this disclosure to the meeting
Matters for resolution4 items
  1. Election of 5 directors

  2. Election of 3 Audit & Supervisory Board Members

  3. Election of 1 alternate Audit & Supervisory Board Member

  4. Matter concerning the gratis issuance of share acquisition rights as stock options

Company proposal only. The company states that there was no shareholder proposal.A shareholder proposal is a resolution submitted by a shareholder, rather than by the company.
Director nominee
5Nominees
1New
2Outside
Resolutions for the General Meeting of Shareholders
ItemDetails
Type of shareholders' meetingAnnual (21st fiscal year)
Date and time28 October 2026 (Wednesday), 2:00 p.m.
Matters for resolutionProposal No. 1: Election of 5 directors, Proposal No. 2: Election of 3 Audit & Supervisory Board Members, Proposal No. 3: Election of 1 alternate Audit & Supervisory Board Member, Proposal No. 4: Matter concerning the gratis issuance of share acquisition rights as stock options
Shareholder ProposalNone
Director nominee5 candidates (1 new, 2 outside directors)
Items this document does not state (1)
Percentage voting in favor

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

To increase the number of directors by 1 in order to expand the business and build a stronger research and development structure going forward.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice of Convocation of the 21st Annual General Meeting of Shareholders | StemRIM Inc. (4599) timely disclosure | Komori